After years of research, we can now modulate how the microbiota influence lung diseases. The commercialization of this work from University of Alabama at Birmingham, led by ResBiotic founder and Chief Scientific Officer C. Vivek Lal MD FAAP, has the potential to be life changing for respiratory disease patients.
Location: United States
Employees: 11-50
Total raised: $17.5M
Founded date: 2020
Funding Rounds 2
| Date | Series | Amount | Investors |
| 13.09.2025 | Series A | $14.5M | Biostack V... |
| 01.05.2021 | Seed | $3M | - |
Mentions in press and media 4
| Date | Title | Description |
| 13.09.2025 | resbiotic Secures $14.5 Million to Expand Its Science-Driven Gut-X Axis Health Platform | resbiotic Nutrition has completed a $14.5 million funding round, including an $8 million Series A led by Sororibus Capital and Biostack Ventures. The new funding will fuel the expansion of the company’s product lineup, support rapid growth ... |
| 02.07.2021 | Advancements Series to Explore Developments in Respiratory Health Technology | JUPITER, Fla. (PRWEB) July 02, 2021 Scheduled to broadcast Q4/2021, Advancements with Ted Danson will focus on how probiotics are being used to transform respiratory health. In this episode of Advancements, the segment will explore how ResB... |
| 01.05.2021 | ResBiotic Raises $3M in Seed Funding | Resbiotic, Inc., a Bilmingham, Ala.-based biotech startup, raised $3M in seed funding. The round was funded from a private equity syndicate led by Timberline Holdings. Braxton Goodrich (Timberline Holdings) will serve on the ResBiotic Board... |
| - | ResBiotic | “Explore ResBiotic™ for groundbreaking probiotic and prebiotic supplements. Our scientifically-backed products are designed to balance your gut for improved overall health.” |